TELMIMAC-HT: Dual-Action Control for Persistent Hypertension
TELMIMAC-HT tablets from MK Healthcare offer an effective combination therapy for the sustained management of High Blood Pressure (Hypertension). This formulation pairs Telmisartan with Hydrochlorothiazide (HCTZ), leveraging two complementary mechanisms to achieve superior blood pressure control. This combination is essential for patients whose hypertension is not adequately managed by monotherapy, providing a potent and reliable way to reduce cardiovascular risk and prevent complications.
Mechanism: Combining ARB Power with Diuretic Action
The efficacy of TELMIMAC-HT is based on its dual action. Telmisartan, an Angiotensin II Receptor Blocker (ARB), works by blocking the action of angiotensin II, a powerful vasoconstrictor. This action relaxes blood vessels and lowers blood pressure effectively. Hydrochlorothiazide (HCTZ), a thiazide diuretic, works by increasing the excretion of water and sodium from the body via the kidneys. This reduces the total fluid volume in the blood, which further contributes to lowering blood pressure. The synergy between the ARB and the diuretic provides comprehensive and sustained anti-hypertensive control.
Key Benefits for Cardiovascular Risk Reduction
TELMIMAC-HT is a critical medication for achieving and maintaining target blood pressure goals, which is paramount for protecting vital organs. By reducing the strain on the heart and blood vessels, this combination therapy significantly lowers the patient's risk profile for serious events such as stroke, heart attack (myocardial infarction), and kidney damage (nephropathy). The convenience of a fixed-dose combination also helps improve patient adherence to their prescribed long-term therapy.
MK Healthcare: Quality and Reliability in Anti-Hypertensive Care
MK Healthcare, an ISO-GMP Certified pharmaceutical company, ensures that TELMIMAC-HT (Telmisartan + Hydrochlorothiazide Tablets) is manufactured under rigorous quality protocols, guaranteeing a safe, effective, and reliable product for chronic disease management. This medication is a cornerstone in our cardiology segment, addressing the widespread need for advanced hypertension control. For healthcare providers and distributors seeking a trusted, high-quality ARB/diuretic combination, TELMIMAC-HT is a premium offering from a dedicated pharmaceutical leader.
What is the primary use of TELMIMAC-HT Tablets?
TELMIMAC-HT is a combination medication primarily used for the treatment of high blood pressure (hypertension). It is typically prescribed to adult patients whose blood pressure is not adequately controlled by a single medication (monotherapy) and is essential for reducing the risk of stroke, heart attack, and kidney damage.
What are the two active ingredients in TELMIMAC-HT and how do they work?
TELMIMAC-HT contains two active components: * Telmisartan (40 mg): An Angiotensin II Receptor Blocker (ARB) that relaxes blood vessels by blocking the action of a naturally occurring hormone (Angiotensin II) that causes them to narrow. * Hydrochlorothiazide (12.5 mg): A diuretic (water pill) that increases urine output, helping the body eliminate excess salt and water, which further lowers blood pressure and reduces fluid retention.
What are the common side effects of TELMIMAC-HT?
Common side effects can include dizziness (especially when standing up quickly), fatigue, nausea, and back pain. Due to the diuretic component, changes in blood electrolyte levels (like low potassium) may also occur.
Can TELMIMAC-HT be taken during pregnancy?
No. TELMIMAC-HT (Telmisartan) is not safe to use during the second and third trimesters of pregnancy as it can cause serious harm to the developing baby. If you are pregnant, planning to become pregnant, or breastfeeding, you must inform your doctor immediately.